JRCT ID: jRCT2080221848
Registered date:04/07/2012
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Healthy Adult |
Date of first enrollment | 04/07/2012 |
Target sample size | 120 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Z-100 INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administration for Investigational material : Subcutaneous injection: 0.02ug/day, 0.2ug/day, 2ug/day, 40ug/day control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Subcutaneous injection |
Outcome(s)
Primary Outcome | Immunological parameter |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 49age old |
Gender | Both |
Include criteria | -Healthy adult -Body mass index of 17.6-26.4 kg/m2 |
Exclude criteria | -Subjects with allergy -Use of any medication within 1 week prior to administer |
Related Information
Primary Sponsor | Zeria Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-121893 |
Contact
Public contact | |
Name | |
Address | 03-5644-7053 |
Telephone | |
Affiliation | Zeria Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |